Маниш Доктор Бийани
О себе
Dr. Manish R Biyani have combine expertise directing multiple initiatives simultaneously using strong time management and prioritization skills. Equipped with B pharm, M pharm (India) & PhD in Organic Chemistry at 𝗛𝗲𝗿𝗶𝗼𝘁-𝗪𝗮𝘁𝘁 𝗨𝗻𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝘆, 𝗨𝗞 alongside strong educational background in higher management. Accomplished 15 years of experience leading complex drug development and pharmaceutical manufacturing projects from concept development through to clinical trials and drug commercialization. Results-driven Pharma Leader with proven success fostering strong collaborative relationships with regulators, key stakeholders, and high-value clients in India, US, UK, Europe. Demonstrated ability to collaborate with stakeholders across R&D groups, quality, manufacturing, regulatory, clinical development, and SCM. Articulate communicator with credible history of cultivating positive partnerships with interdepartmental teams, management peers, and key clientele to realize strategic business goals.
Demonstrated capabilities in IPR, Corporate strategy, Project management, SCM, Technology evaluation, Digital transformation, Business intelligence (Data Analytics & Market research). He enables organization with project governance framework, multi-country patent strategy, business insights, Aligning business with Risk, Strategy & P & L
►Committed Project Management Professional with demonstrated expertise establishing project governance framework to plan, monitor, and control project deliverables, to identify and mitigate risks, and to complete projects on-time and within budget.
►Trusted resource to executive leadership team in relation to multi-country patent strategy development and patent filing, being granted over 𝐭𝐞𝐧 𝗽𝗮𝘁𝗲𝗻𝘁𝘀 in drug discovery and development.
►Committed Professional leveraging key market analysis skills to identify $ 𝟮𝗠 potential savings by competitive landscape
Strong background working in multiple start-ups & ability of exploring novel concepts in pharmaceutical, nutraceutical & food & beverage industries. As my professional career continues to evolve, I remain steadfast in my belief that collaboration is the key to business & thus committed to building positive relationships with interdepartmental teams, senior management, & key clientele. It is through these bonds that deals are closed and organizational goals are achieved.
Major areas of Research have been on Preclinical & clinical in drug-induced liver injury, anti-oxidant studies, Toxicological studies, CNS, immunology, neurobiology, addiction, DNA damage, oligonucleotide research, inflammation, & gout. Organic Chemistry experience in API process development, and multi-step NCE synthesis in areas such as nucleic acid synthesis, carbohydrates, macrolides (Antibiotics) and heterocyclic compounds & chiral separation (chiral auxiliaries & resolving agents).
Области научных интересов
Топ-100
Области наук
|
1
|
|
|
Biochemistry
|
Biochemistry, 1, 33.33%
Biochemistry
1 публикация, 33.33%
|
|
Medicine (miscellaneous)
|
Medicine (miscellaneous), 1, 33.33%
Medicine (miscellaneous)
1 публикация, 33.33%
|
|
General Medicine
|
General Medicine, 1, 33.33%
General Medicine
1 публикация, 33.33%
|
|
Pharmacology
|
Pharmacology, 1, 33.33%
Pharmacology
1 публикация, 33.33%
|
|
Food Science
|
Food Science, 1, 33.33%
Food Science
1 публикация, 33.33%
|
|
Neurology
|
Neurology, 1, 33.33%
Neurology
1 публикация, 33.33%
|
|
Nutrition and Dietetics
|
Nutrition and Dietetics, 1, 33.33%
Nutrition and Dietetics
1 публикация, 33.33%
|
|
Toxicology
|
Toxicology, 1, 33.33%
Toxicology
1 публикация, 33.33%
|
|
Behavioral Neuroscience
|
Behavioral Neuroscience, 1, 33.33%
Behavioral Neuroscience
1 публикация, 33.33%
|
|
Health (social science)
|
Health (social science), 1, 33.33%
Health (social science)
1 публикация, 33.33%
|
|
1
|
Журналы
|
1
|
|
|
Alcohol
1 публикация, 33.33%
|
|
|
Journal of Functional Foods
1 публикация, 33.33%
|
|
|
Phytotherapy Research
1 публикация, 33.33%
|
|
|
1
|
Цитирующие журналы
|
1
2
3
|
|
|
Журнал не определён
|
Журнал не определён, 3, 8.82%
Журнал не определён
3 цитирования, 8.82%
|
|
Phytotherapy Research
3 цитирования, 8.82%
|
|
|
Dermatologic Therapy
2 цитирования, 5.88%
|
|
|
Nutrients
2 цитирования, 5.88%
|
|
|
Alcohol
2 цитирования, 5.88%
|
|
|
Drugs and Drug Candidates
2 цитирования, 5.88%
|
|
|
Colloids and Surfaces B: Biointerfaces
1 цитирование, 2.94%
|
|
|
PeerJ
1 цитирование, 2.94%
|
|
|
Pharmacological Research
1 цитирование, 2.94%
|
|
|
Phytomedicine
1 цитирование, 2.94%
|
|
|
Medicinal Chemistry Research
1 цитирование, 2.94%
|
|
|
JAOCS, Journal of the American Oil Chemists' Society
1 цитирование, 2.94%
|
|
|
Annals of Medicine
1 цитирование, 2.94%
|
|
|
Experimental Eye Research
1 цитирование, 2.94%
|
|
|
Journal of Functional Foods
1 цитирование, 2.94%
|
|
|
Food and Function
1 цитирование, 2.94%
|
|
|
Journal of Ethnopharmacology
1 цитирование, 2.94%
|
|
|
Antioxidants
1 цитирование, 2.94%
|
|
|
Metabolites
1 цитирование, 2.94%
|
|
|
Current Drug Metabolism
1 цитирование, 2.94%
|
|
|
Food Chemistry
1 цитирование, 2.94%
|
|
|
Drug and Chemical Toxicology
1 цитирование, 2.94%
|
|
|
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
1 цитирование, 2.94%
|
|
|
Egyptian Liver Journal
1 цитирование, 2.94%
|
|
|
American Journal of Plant Sciences
1 цитирование, 2.94%
|
|
|
Experimental and Clinical Gastroenterology
1 цитирование, 2.94%
|
|
|
1
2
3
|
Издатели
|
1
2
|
|
|
Elsevier
2 публикации, 66.67%
|
|
|
Wiley
1 публикация, 33.33%
|
|
|
1
2
|
Организации из публикаций
|
1
2
3
|
|
|
Университет Крейтона
3 публикации, 100%
|
|
|
Медицинский колледж и больница, Калькутта
1 публикация, 33.33%
|
|
|
1
2
3
|
Страны из публикаций
|
1
2
3
|
|
|
США
|
США, 3, 100%
США
3 публикации, 100%
|
|
Индия
|
Индия, 3, 100%
Индия
3 публикации, 100%
|
|
1
2
3
|
Цитирующие организации
Цитирующие страны
|
2
4
6
8
10
|
|
|
Китай
|
Китай, 10, 29.41%
Китай
10 цитирований, 29.41%
|
|
США
|
США, 5, 14.71%
США
5 цитирований, 14.71%
|
|
Индия
|
Индия, 5, 14.71%
Индия
5 цитирований, 14.71%
|
|
Страна не определена
|
Страна не определена, 4, 11.76%
Страна не определена
4 цитирования, 11.76%
|
|
Египет
|
Египет, 2, 5.88%
Египет
2 цитирования, 5.88%
|
|
Иран
|
Иран, 2, 5.88%
Иран
2 цитирования, 5.88%
|
|
Италия
|
Италия, 2, 5.88%
Италия
2 цитирования, 5.88%
|
|
Республика Корея
|
Республика Корея, 2, 5.88%
Республика Корея
2 цитирования, 5.88%
|
|
Саудовская Аравия
|
Саудовская Аравия, 2, 5.88%
Саудовская Аравия
2 цитирования, 5.88%
|
|
Россия
|
Россия, 1, 2.94%
Россия
1 цитирование, 2.94%
|
|
Австрия
|
Австрия, 1, 2.94%
Австрия
1 цитирование, 2.94%
|
|
Бразилия
|
Бразилия, 1, 2.94%
Бразилия
1 цитирование, 2.94%
|
|
Великобритания
|
Великобритания, 1, 2.94%
Великобритания
1 цитирование, 2.94%
|
|
Испания
|
Испания, 1, 2.94%
Испания
1 цитирование, 2.94%
|
|
Канада
|
Канада, 1, 2.94%
Канада
1 цитирование, 2.94%
|
|
Малайзия
|
Малайзия, 1, 2.94%
Малайзия
1 цитирование, 2.94%
|
|
Непал
|
Непал, 1, 2.94%
Непал
1 цитирование, 2.94%
|
|
ОАЭ
|
ОАЭ, 1, 2.94%
ОАЭ
1 цитирование, 2.94%
|
|
Тунис
|
Тунис, 1, 2.94%
Тунис
1 цитирование, 2.94%
|
|
2
4
6
8
10
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика пересчитывается раз в сутки.